0001123292-17-001465.txt : 20171002 0001123292-17-001465.hdr.sgml : 20171002 20171002165438 ACCESSION NUMBER: 0001123292-17-001465 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170928 FILED AS OF DATE: 20171002 DATE AS OF CHANGE: 20171002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Graff Fred CENTRAL INDEX KEY: 0001667407 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36329 FILM NUMBER: 171115099 MAIL ADDRESS: STREET 1: C/O RECRO PHARMA, INC. STREET 2: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Recro Pharma, Inc. CENTRAL INDEX KEY: 0001588972 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261523233 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (484) 395-2400 MAIL ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2017-09-28 0001588972 Recro Pharma, Inc. REPH 0001667407 Graff Fred C/O RECRO PHARMA, INC. 490 LAPP ROAD MALVERN PA 19355 0 1 0 0 Chief Commercial Officer Common Stock 2017-09-28 4 M 0 2000 A 10000 D On September 28, 2017, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to 2,000 performance-based restricted stock units, which were converted into 2,000 shares of common stock on a one-for-one basis. /s/ Ryan D. Lake, attorney-in-fact 2017-10-02